TABLE 2.
Seroprevalence of anti-F protein, anti-F99 synthetic peptide, and anticore antibodies in168 HCV-infected patients by ELISA
| HCV-infected patients | Seroprevalence of antibodya to:
|
||
|---|---|---|---|
| F protein | Core protein | F99 synthetic peptide | |
| All patients | 114/168 (68) | 160/168 (95) | 61/168 (36) |
| Patients with the following HCV genotype: | |||
| 1b | 73/104 (70) | 97/104 (93) | 44/104 (42) |
| 1a | 0/1 (0) | 1/1 (100) | 0/1 (0) |
| 2a | 11/16 (69) | 16/16 (100) | 5/16 (31) |
| 3a | 6/11 (55) | 11/11 (100) | 4/11 (36) |
| 3b | 3/5 (60) | 5/5 (100) | 1/5 (20) |
| 6 | 0/1 (0) | 0/1 (0) | 0/1 (0) |
| NDb | 21/30 (70) | 30/30 (100) | 7/30 (23) |
a
Values are the numbers of positive serum or plasma samples/number of samples tested. The values in parentheses are percentages.
b
ND, not documented.